Study to Assess OPB-31121 in Advanced Leukemias or Myelodysplastic Syndromes

This study has been terminated.

(Colloborator-Sponsor decision to terminate.)

Sponsor:

Collaborator:

Otsuka Pharmaceutical Co., Ltd.

Information provided by (Responsible Party):

M.D. Anderson Cancer Center

ClinicalTrials.gov Identifier:

NCT01029509

First received: December 8, 2009

Last updated: July 19, 2012

Last verified: July 2012

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	August 2011
Primary Completion Date:	August 2011 (Final data collection date for primary outcome measure)